Farzan Nima 4
4 · Keros Therapeutics, Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Farzan Nima
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-30+10,000→ 10,000 totalExercise: $46.31Exp: 2034-05-29→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.